Results 51 to 60 of about 609 (139)

Anatomical and Functional Outcomes of Anti-VEGF Therapy in Pachychoroid Neovasculopathy. [PDF]

Clin Ophthalmol
Evaluation of real-life effectiveness of anti-VEGF therapy in patients diagnosed with pachychoroid neovasculopathy (PNV).This retrospective analysis included central serous chorioretinopathy (CSC) patients who developed PNV and underwent anti-VEGF treatment. Individuals with concomitant retinal diseases were excluded.
Sitnilska V, Pohl JM, Tang Y, Löw K, Lammert JQ, Krohne TU, Altay L.   +6 more
europepmc   +5 more sources

Central serous chorioretinopathy: A review

Clinical &Experimental Ophthalmology, Volume 51, Issue 3, Page 243-270, April 2023., 2023
Abstract Central serous chorioretinopathy (CSC) is the fourth most common non‐surgical retinopathy associated with fluid leakage. The pathogenesis is not yet completely understood, but changes in the choroid, sclera and RPE have been described associated with venous congestion of choroidal outflow.
Adrian T. Fung, Yi Yang, Andrew W. Kam
wiley   +1 more source

Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities

Acta Ophthalmologica, Volume 100, Issue 8, Page 946-959, December 2022., 2022
Abstract The pachychoroid disease spectrum (PDS) includes several chorioretinal diseases that share specific choroidal abnormalities. Although their pathophysiological basis is poorly understood, diseases that are part of the PDS have been hypothesized to be the result of venous congestion.
Joost Brinks, Elon H. C. van Dijk, Onno C. Meijer, Reinier O. Schlingemann, Camiel J. F. Boon   +4 more
wiley   +1 more source

Pachychoroid Spectrum Disorder Findings in Patients with Coronavirus Disease 2019

Case Reports in Ophthalmological Medicine, Volume 2021, Issue 1, 2021., 2021
Purpose. To report the occurrence of acute, bilateral, central serous chorioretinopathy (CSC), and pachychoroid spectrum disorder findings in patients with coronavirus disease 2019 (COVID‐19). Methods. In recovered cases of COVID‐19 with visual disturbances, complete ocular examinations with multimodal retinal and choroidal evaluation, including ...
Mojtaba Abrishami, Ramin Daneshvar, Nasser Shoeibi, Neda Saeedian, Hamid Reza Heidarzadeh, Seyedeh Maryam Hosseini, Stephen G. Schwartz   +6 more
wiley   +1 more source

Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy. [PDF]

Sci Rep, 2019
AbstractThis retrospective study was to compare the efficacy of intravitreal injection of ranibizumab and aflibercept for patients with pachychoroid neovasculopathy. 54 eyes were initially treated with 3 monthly loading injections of ranibizumab or aflibercept. Treatment switching from ranibizumab to aflibercept, and aflibercept to photodynamic therapy
Jung BJ, Kim JY, Lee JH, Baek J, Lee K, Lee WK.   +5 more
europepmc   +4 more sources

The Contemporary Role of Photodynamic Therapy in the Treatment of Pachychoroid Diseases

Journal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021
Recent advances in retinal imaging technology have improved our understanding in the pathogenesis and evolvement of various chorioretinal diseases. Central serous chorioretinopathy and polypoidal choroidal vasculopathy are now recognized to belong to the same spectrum of disorders known as pachychoroid diseases.
Lawrence P. L. Iu, Ho Yan Chan, Mary Ho, Frank H. P. Lai, Andrew C. Y. Mak, Raymond L. M. Wong, Alvin L. Young, Alessandro Meduri   +7 more
wiley   +1 more source

Clinical Characteristics of Neovascular Age‐Related Macular Degeneration without Typical Drusen

Journal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021
Purpose. To evaluate the clinical characteristics of neovascular age‐related macular degeneration (nAMD) patients without typical drusen. Methods. We retrospectively studied 165 eyes in 165 patients with treatment‐naïve nAMD, including typical AMD and polypoidal choroidal vasculopathy (PCV).
Hiroyuki Kamao, Katsutoshi Goto, Kento Matsuno, Kenichi Mizukawa, Atsushi Miki, Junichi Kiryu, Akio Oishi   +6 more
wiley   +1 more source

Applications of Multimodal Imaging in Central Serous Chorioretinopathy Evaluation

Journal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021
Central serous chorioretinopathy (CSCR) is a macular disease characterized by serous retinal detachment commonly involving the macular region. CSCR has a wide spectrum of clinical presentations. Although a significant proportion of CSCR cases are self‐limiting, patients can suffer from persistent or recurrent disease, sometimes complicated with ...
Mary Ho, Gabriel Li, Andrew Mak, Danny Ng, Lawrence Iu, Frank Lai, Dirk Sandner   +6 more
wiley   +1 more source

Prevalence of focal lamina cribrosa defects in eyes with pachychoroid disease spectrum [PDF]

International Journal of Ophthalmology, 2022
AIM: To determine the prevalence of focal lamina cribrosa (LC) defect among patients with pachychoroid disease spectrum (PDS) in the absence of peripapillary retinoschisis. METHODS: This retrospective, cross-sectional study comprised of 180 patients with
Hae Min Kang, Na Eun Lee, Jeong Hoon Choi, Hyoung Jun Koh, Sung Chul Lee   +4 more
doaj   +1 more source

OCT Biomarkers in Neovascular Age‐Related Macular Degeneration: A Narrative Review

Journal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021
Age‐related macular degeneration (AMD) is the leading cause of legal blindness in elderly people. Neovascular AMD (nAMD) is responsible for the majority of cases of severe visual loss in eyes with AMD. Optical coherence tomography (OCT) is the most widely used technology for the diagnosis and follow‐up of nAMD patients, which is widely used to study ...
Cristian Metrangolo, Simone Donati, Marco Mazzola, Liviana Fontanel, Walter Messina, Giulia D’alterio, Marisa Rubino, Paolo Radice, Elias Premi, Claudio Azzolini, Serena Fragiotta   +10 more
wiley   +1 more source